Skip to content

Xconomy

Business, Life Sciences, and Technology News

  • Our Regions
    • Boston
    • Boulder/Denver
    • Detroit
    • Europe
    • Indiana
    • National
    • New York
    • Philadelphia
    • Raleigh-Durham
    • San Diego
    • San Francisco
    • Seattle
    • Texas
    • Wisconsin

Apple Buys Ignition-Backed Lala, Appature Gets Funded, Free & Clear Gets Celebrated, & More Seattle-Area Deals News

It was another fairly quiet week for deals in the Northwest. But there were a couple of first-round venture financings for established software startups, and one notable acquisition.

—Portland, OR-based software startup JanRain closed $3.25 million in Series A financing led by DFJ Frontier, with participation from Anthem Venture Partners and RPM Ventures. JanRain’s software helps website operators register visitors more easily using universal logins. It also helps consumers port their Web identities and share their experiences on social networks like Twitter and Facebook.

—Seattle-based Appature, a healthcare marketing startup, raised $3.5 million in first-round funding from Ignition Partners and Madrona Venture Group. Seattle seed-stage fund Founder’s Co-op also participated. Appature was founded in 2007 and is already profitable, with big customers like Johnson & Johnson and Microsoft Health Solutions Group. Its software helps companies in the broader healthcare industry deliver and track marketing campaigns and understand their customers better online.

—Lala, an online music service based in Palo Alto, CA, and backed by Bellevue, WA-based Ignition Partners and Boston-based Bain Capital Ventures, is being acquired by Apple (NASDAQ: [[ticker:AAPL]]) in a deal of undisclosed size. The deal was first reported by Bloomberg and CNET, and has since been confirmed by Reuters and other outlets. Lala lets users store music on Internet servers rather than download songs to their computer as with iTunes.

—Seattle-based Free & Clear, the developer of a proprietary smoking cessation program, won “Deal of the Year” from the Evergreen Venture Capital Association, as Luke reported. Free & Clear, which was backed by $17 million in capital from Polaris Venture Partners, Three Arch Partners, and Kaiser Permanente Ventures, was acquired by Waltham, MA-based Inverness Medical Innovations (NYSE: [[ticker:IMA]]) for $130 million in September.

—Redmond, WA-based Microvision (NASDAQ: [[ticker:MVIS]]), a developer of light display technologies, raised $9.3 million in a stock offering, as Luke reported. The company sold 3.33 million shares, at $3 apiece, to a single existing institutional investor. Oppenheimer & Co. was the book-running manager of the offering, and Craig Hallum Capital served as co-manager.

Author: Gregory T. Huang

Greg is a veteran journalist who has covered a wide range of science, technology, and business. As former editor in chief, he overaw daily news, features, and events across Xconomy's national network. Before joining Xconomy, he was a features editor at New Scientist magazine, where he edited and wrote articles on physics, technology, and neuroscience. Previously he was senior writer at Technology Review, where he reported on emerging technologies, R&D, and advances in computing, robotics, and applied physics. His writing has also appeared in Wired, Nature, and The Atlantic Monthly’s website. He was named a New York Times professional fellow in 2003. Greg is the co-author of Guanxi (Simon & Schuster, 2006), about Microsoft in China and the global competition for talent and technology. Before becoming a journalist, he did research at MIT’s Artificial Intelligence Lab. He has published 20 papers in scientific journals and conferences and spoken on innovation at Adobe, Amazon, eBay, Google, HP, Microsoft, Yahoo, and other organizations. He has a Master’s and Ph.D. in electrical engineering and computer science from MIT, and a B.S. in electrical engineering from the University of Illinois, Urbana-Champaign. View all posts by Gregory T. Huang

Author Gregory T. HuangPosted on December 8, 2009December 7, 2009

Post navigation

Previous Previous post: ZymoGenetics Sells Inflammatory Drug to Old Parent, Novo Nordisk, for $24M Upfront
Next Next post: Arzeda Gets Federal Grant to Make Renewable Enzyme for Tires, Sidesteps VC Funding Model
  • Our Regions
    • Boston
    • Boulder/Denver
    • Detroit
    • Europe
    • Indiana
    • National
    • New York
    • Philadelphia
    • Raleigh-Durham
    • San Diego
    • San Francisco
    • Seattle
    • Texas
    • Wisconsin
Xconomy Proudly powered by WordPress